0001127602-21-012726.txt : 20210402
0001127602-21-012726.hdr.sgml : 20210402
20210402170959
ACCESSION NUMBER: 0001127602-21-012726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210331
FILED AS OF DATE: 20210402
DATE AS OF CHANGE: 20210402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ICAHN BRETT
CENTRAL INDEX KEY: 0001387184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 21802819
MAIL ADDRESS:
STREET 1: C/O ICAHN ENTERPRISES L.P.
STREET 2: 16690 COLLINS AVE., PH
CITY: SUNNY ISLES
STATE: FL
ZIP: 33160
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-03-31
0000885590
Bausch Health Companies Inc.
BHC
0001387184
ICAHN BRETT
400 SOMERSET CORPORATE BLVD.
BRIDGEWATER
NJ
08807
1
Common Shares, No Par Value
2021-03-31
4
A
0
126
31.74
A
870
D
Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.
/s/ Kirsten O'Donnell, attorney-in-fact for Brett Icahn
2021-04-02